Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16780325rdf:typepubmed:Citationlld:pubmed
pubmed-article:16780325lifeskim:mentionsumls-concept:C0444626lld:lifeskim
pubmed-article:16780325lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:16780325lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:16780325lifeskim:mentionsumls-concept:C0043309lld:lifeskim
pubmed-article:16780325lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:16780325lifeskim:mentionsumls-concept:C2347051lld:lifeskim
pubmed-article:16780325lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:16780325lifeskim:mentionsumls-concept:C0077281lld:lifeskim
pubmed-article:16780325lifeskim:mentionsumls-concept:C0043781lld:lifeskim
pubmed-article:16780325pubmed:issue13lld:pubmed
pubmed-article:16780325pubmed:dateCreated2006-6-19lld:pubmed
pubmed-article:16780325pubmed:abstractTextThis report describes the synthesis and characterization of a series of novel biscapped and monocapped tris(dioxime) Mn(II) complexes [Mn(dioxime)3(BR)2] and [Mn(dioxime)3BR]+ (dioxime = cyclohexanedione dioxime (CDOH2) and 1,2-dimethylglyoxyl dioxime (DMGH(2)); R = Me, n-Bu, and Ph). All tris(dioxime) Mn(II) complexes have been characterized by elemental analysis, IR, UV/vis, cyclic voltammetry, ESI-MS, and, in the cases of [Mn(CDOH)3BPh]OH.CHCl3 and [Mn(CDO)(CDOH)2(BBu(OC2H5))2], X-ray crystallography. It was found that biscapped Mn(II) complexes [Mn(dioxime)3(BR)2] are not stable in the presence of water and readily hydrolyze to form monocapped cationic complexes [M(dioxime)3BR]+. This instability is most likely caused by mismatch between the size of Mn(II) and the coordination cavity of the biscapped tris(dioxime) ligands. In contrast, monocapped cationic complexes [M(dioxime)3BR]+ are very stable in aqueous solution even in the presence of PDTA (1,2-diaminopropane-N,N,N',N'-tetraacetic acid) because of the kinetic inertness imposed by the monocapped tris(dioxime) chelators that are able to completely "wrap" Mn(II) into their N6 coordination cavity. [Mn(CDO)3BPh]OH has a distorted trigonal prismatic coordination geometry, with the Mn(II) being bonded by six imine-N donors. The hydroxyl groups from three dioxime chelating arms form very strong intramolecular hydrogen bonds with the hydroxide counterion so that the structure of [Mn(CDOH)3BPh]OH can be considered as being the clathrochelate with the hydroxide counterion as a "cap".lld:pubmed
pubmed-article:16780325pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:languageenglld:pubmed
pubmed-article:16780325pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:citationSubsetIMlld:pubmed
pubmed-article:16780325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16780325pubmed:statusMEDLINElld:pubmed
pubmed-article:16780325pubmed:monthJunlld:pubmed
pubmed-article:16780325pubmed:issn0020-1669lld:pubmed
pubmed-article:16780325pubmed:authorpubmed-author:LiuShuangSlld:pubmed
pubmed-article:16780325pubmed:authorpubmed-author:HsiehWen-Yuan...lld:pubmed
pubmed-article:16780325pubmed:issnTypePrintlld:pubmed
pubmed-article:16780325pubmed:day26lld:pubmed
pubmed-article:16780325pubmed:volume45lld:pubmed
pubmed-article:16780325pubmed:ownerNLMlld:pubmed
pubmed-article:16780325pubmed:authorsCompleteYlld:pubmed
pubmed-article:16780325pubmed:pagination5034-43lld:pubmed
pubmed-article:16780325pubmed:dateRevised2011-9-26lld:pubmed
pubmed-article:16780325pubmed:meshHeadingpubmed-meshheading:16780325...lld:pubmed
pubmed-article:16780325pubmed:meshHeadingpubmed-meshheading:16780325...lld:pubmed
pubmed-article:16780325pubmed:meshHeadingpubmed-meshheading:16780325...lld:pubmed
pubmed-article:16780325pubmed:meshHeadingpubmed-meshheading:16780325...lld:pubmed
pubmed-article:16780325pubmed:meshHeadingpubmed-meshheading:16780325...lld:pubmed
pubmed-article:16780325pubmed:meshHeadingpubmed-meshheading:16780325...lld:pubmed
pubmed-article:16780325pubmed:meshHeadingpubmed-meshheading:16780325...lld:pubmed
pubmed-article:16780325pubmed:meshHeadingpubmed-meshheading:16780325...lld:pubmed
pubmed-article:16780325pubmed:meshHeadingpubmed-meshheading:16780325...lld:pubmed
pubmed-article:16780325pubmed:meshHeadingpubmed-meshheading:16780325...lld:pubmed
pubmed-article:16780325pubmed:meshHeadingpubmed-meshheading:16780325...lld:pubmed
pubmed-article:16780325pubmed:year2006lld:pubmed
pubmed-article:16780325pubmed:articleTitleNovel biscapped and monocapped tris(dioxime) Mn(II) complexes: x-ray crystal structure of the first cationic tris(dioxime) Mn(II) complex [Mn(CDOH)3BPh]OH (CDOH2= 1,2-cyclohexanedione dioxime).lld:pubmed
pubmed-article:16780325pubmed:affiliationDepartment of Industrial & Physical Pharmacy, School of Health Sciences, Purdue University, 550 Stadium Mall Drive, West Lafayette, Indiana 47907, USA.lld:pubmed
pubmed-article:16780325pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16780325pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16780325pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed